Sean Stalfort is president of the PBM Capital Group where he sources and structures new investment opportunities, oversees many of the healthcare portfolio companies and serves on the board of directors for Dova Pharmaceuticals, Verrica Pharmaceuticals, Xalud Therapeutics, and Quantapore, Inc. Prior to joining PBM Capital, he was the executive vice president for new business development/M&A for PBM Products where he managed new growth opportunities internationally as well as various capital market activities through the sale of the company to Perrigo Corporation for over $800 million. Mr. Stalfort is also a founding partner of Octagon Partners and Octagon Finance. Previously, he was a founding principal and senior vice president of capital markets with Enterprise Mortgage, a vice president in Greenwich Capital’s Asset-Backed Finance Group where he structured over $2 billion in various securitized transactions. Mr. Stalfort graduated from Brown University with a B.A. in business economics and political science.